Ironwood Pharmaceuticals (IRWD) Total Debt (2013 - 2026)
Ironwood Pharmaceuticals (IRWD) posted Total Debt of $584.9 million for Q1 2026, little changed sequentially from $584.7 million in Q4 2025, and up 51.91% YoY from $385.0 million in Q1 2025.
Ironwood Pharmaceuticals (IRWD) Total Debt (2013 - 2026) Analysis & Trends
Ironwood Pharmaceuticals has reported Total Debt for 13 years, with the latest figure at $584.9 million in Q1 2026.
- Quarterly Total Debt rose 51.91% year-over-year to $584.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $584.9 million (up 51.91% YoY) and the FY2025 annual result came in at $584.7 million, up 51.86% from the prior year.
- Total Debt steadied at $584.9 million in Q1 2026 per IRWD's latest filing, from $584.7 million in the prior quarter.
- Over five years, Total Debt peaked at $599.1 million in Q2 2023 and troughed at $120.6 million in Q1 2022.
- A 5-year average of $473.2 million and a median of $499.6 million in 2023 frame the typical range for Total Debt.
- The sharpest annual moves came in 2024 and 2026: Total Debt declined 29.06% in 2024, then soared 51.91% in 2026.
- Over 5 years, Total Debt stood at $120.6 million in 2022, then soared by 314.29% to $499.6 million in 2023, then decreased by 22.93% to $385.0 million in 2024, then surged by 51.86% to $584.7 million in 2025, then grew by 0.03% to $584.9 million in 2026.
- According to Business Quant data, Total Debt over the past three periods registered $584.9 million, $584.7 million, and $584.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | -5.81 Bn |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | 16.59 Bn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | 9.05 Bn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 31.47 Bn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 13.35 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 3.92 Bn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | 760.00 Mn |
| 10 | Ironwood Pharmaceuticals | 676.53 Mn | 597.40 Mn | - | 385.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 385.00 Mn |
| Mar 31, 2026 | 584.86 Mn |
| Dec 31, 2025 | 584.68 Mn |
| Sep 30, 2025 | 584.51 Mn |
| Jun 30, 2025 | 584.33 Mn |
| Mar 31, 2025 | 385.00 Mn |
| Dec 31, 2024 | 385.00 Mn |
| Sep 30, 2024 | 400.00 Mn |
| Jun 30, 2024 | 425.00 Mn |
| Mar 31, 2024 | 474.80 Mn |
| Dec 31, 2023 | 499.56 Mn |
| Sep 30, 2023 | 524.32 Mn |
| Jun 30, 2023 | 599.08 Mn |
| Mar 31, 2022 | 120.58 Mn |
| Dec 31, 2021 | 116.86 Mn |
| Sep 30, 2021 | 114.83 Mn |
| Jun 30, 2021 | 112.85 Mn |
| Jun 30, 2019 | 78.33 Mn |
| Mar 31, 2019 | 90.14 Mn |
| Dec 31, 2018 | 100.59 Mn |